Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Sammons, Sarah, Yi Ren, Jeremy Force, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Jennifer K. Plichta, Gretchen Kimmick, et al. “Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer.” In Poster Session Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7445.sabcs19-p3-08-10.

Full Text

Rosenberger, Laura H., Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Oluwadamilola M. Fayanju, E Shelley Hwang, and Jennifer K. Plichta. “Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?” In Breast Cancer Res Treat, 179:661–70, 2020. https://doi.org/10.1007/s10549-019-05500-9.

Full Text

Plichta, Jennifer K., Samantha M. Thomas, Rebecca Vernon, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.” In Breast Cancer Res Treat, 180:227–35, 2020. https://doi.org/10.1007/s10549-020-05542-4.

Full Text

Fayanju, Oluwadamilola M., Yi Ren, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Gita Suneja, et al. “Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.” Breast Cancer Res Treat 180, no. 1 (February 2020): 207–17. https://doi.org/10.1007/s10549-020-05529-1.

Full Text

Fayanju, Oluwadamilola M., Yi Ren, Gita Suneja, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Terry Hyslop, and E Shelley Hwang. “Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.” Int J Radiat Oncol Biol Phys 106, no. 2 (February 1, 2020): 377–89. https://doi.org/10.1016/j.ijrobp.2019.10.039.

Full Text

Plichta, Jennifer K., Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, and E Shelley Hwang. “Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.” Ann Surg 271, no. 1 (January 2020): 169–76. https://doi.org/10.1097/SLA.0000000000003071.

Full Text

Landercasper, Jeffrey, Andrew J. Borgert, Oluwadamilola M. Fayanju, Hiram Cody, Sheldon Feldman, Caprice Greenberg, Jared Linebarger, Barbara Pockaj, and Lee Wilke. “Correction to: Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members.” Annals of Surgical Oncology 26, no. Suppl 3 (December 2019): 891. https://doi.org/10.1245/s10434-019-07799-6.

Full Text

Plichta, Jennifer K., Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Nina Tamirisa, Terry Hyslop, and E Shelley Hwang. “Clinical and pathological stage discordance among 433,514 breast cancer patients.” Am J Surg 218, no. 4 (October 2019): 669–76. https://doi.org/10.1016/j.amjsurg.2019.07.016.

Full Text

Champion, Cosette D., Yi Ren, Samantha M. Thomas, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Rachel A. Greenup, Carolyn S. Menendez, E Shelley Hwang, and Jennifer K. Plichta. “DCIS with Microinvasion: Is It In Situ or Invasive Disease?” In Ann Surg Oncol, 26:3124–32, 2019. https://doi.org/10.1245/s10434-019-07556-9.

Full Text

Pages